These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 472338)

  • 1. Indomethacin increases abortifacient effect of PGE2 in man.
    Piotrowski J; Basta A; Klimczyk K; Małolepazy A; Dłuzniewska M; Spławinski JA
    Prostaglandins; 1979 Mar; 17(3):451-9. PubMed ID: 472338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy.
    Swahn ML; Ugocsai G; Bygdeman M; Kovacs L; Belsey EM; Van Look PF
    Hum Reprod; 1989 Jan; 4(1):21-8. PubMed ID: 2651472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion.
    Rodger MW; Baird DT
    Br J Obstet Gynaecol; 1990 Jan; 97(1):41-5. PubMed ID: 2407284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin E2 induction of abortion and fetal demise.
    Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
    Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Intravenous prostaglandins and oxytocin for mid-trimester abortion.
    Coltart TM; Coe MJ
    Lancet; 1975 Jan; 1(7899):173-4. PubMed ID: 46097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the third stage of labor in pregnancies terminated by prostaglandin E2.
    Kirz DS; Haag MK
    Am J Obstet Gynecol; 1989 Feb; 160(2):412-4. PubMed ID: 2916627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostaglandin-oxytocin enhancement.
    Seppälä M; Vara P
    Br Med J; 1972 Mar; 1(5802):747. PubMed ID: 5015335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramuscular administration of 15(S) 15 methyl prostaglandin E2 methyl ester for induction of abortion: a comparison of two dose schedules.
    Brenner WE; Dingfelder JR; Staurovsky LG; Kumarasamy T; Grimes DA
    Fertil Steril; 1975 Apr; 26(4):369-79. PubMed ID: 1116632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
    Bieniarz J; Hunter G; Scommegna A
    Am J Obstet Gynecol; 1974 Nov; 120(6):840-3. PubMed ID: 4429095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine action after induction of labour with oral prostaglandin E2 tablets compared with intravenous oxytocin.
    Elder MG
    Br J Obstet Gynaecol; 1975 Aug; 82(8):674-81. PubMed ID: 1180955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of second trimester pregnancy by intramuscular injection of 16-phenoxy-omega-17,18,19,20-tetranor-PGE2 methyl sulphonylamide.
    Int J Gynaecol Obstet; 1982 Oct; 20(5):383-6. PubMed ID: 6128270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a local effect of intracervical prostaglandin E2-gel.
    Forman A; Ulmsten U; Bányai J; Wingerup L; Uldbjerg N
    Am J Obstet Gynecol; 1982 Aug; 143(7):756-60. PubMed ID: 6954849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
    Borten M; DiLeo LA; Friedman EA
    Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical comparison of abortifacient activity of vaginally administered prostaglandin E2 in two dosage forms.
    Roseman TJ; Gutknecht GD; Stehle RG; Southern EM
    Am J Obstet Gynecol; 1977 Sep; 129(2):225-7. PubMed ID: 19973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of second trimester abortion with mifepristone and gemeprost.
    Thong KJ; Baird DT
    Br J Obstet Gynaecol; 1993 Aug; 100(8):758-61. PubMed ID: 8399016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of pregnancy by prostaglandin 15-methyl F2alpha.
    Bolognese RJ; Corson SL
    Fertil Steril; 1975 Jul; 26(7):695-9. PubMed ID: 1149900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interruption of first trimester human pregnancy following Epostane therapy. Effect of prostaglandin E2 pessaries.
    Webster MA; Phipps SL; Gillmer MD
    Br J Obstet Gynaecol; 1985 Sep; 92(9):963-8. PubMed ID: 3862427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.